StockNews.com cut shares of Chemed (NYSE:CHE – Free Report) from a buy rating to a hold rating in a research report released on Friday. Several other equities analysts also recently weighed in on the company. Oppenheimer raised their price target on Chemed from $625.00 to $650.00 and gave the stock an outperform rating in a […]

Related Keywords

Canada , Chicago , Illinois , United States , Spencers Lee , Michaeld Witzeman , , Chemed Company Profile , Securities Exchange Commission , Royal Bank , Raymond James Associates , Point Inc , Chemed Corporation , Chicago Capital , Charles Schwab Investment Management Inc , Free Report , Get Free Report , Exchange Commission , Teachers Pension Plan Board , Charles Schwab Investment Management , Schwab Investment Management , Chemed Daily ,